COMBINING RADIOLOGY AND ENVISIA, A MOLECULAR CLASSIFIER, TO IMPROVE USUAL INTERSTITIAL PNEUMONIA (UIP) DIAGNOSIS
Sadia Benzaquen(University of Cincinnati), P. Sean Walsh(Veracyte (United States)), Kevin R. Flaherty(University of Michigan), Ganesh Raghu(University of Washington), Navdeep Rai, Lars Hagmeyer(Krankenhaus Bethanien), Amy Hajari Case(The Ocean Cleanup), Brandon T. Larsen(Mayo Clinic in Arizona), Kevin M. Brown(National Cancer Institute), Jeffrey L. Myers(University of Michigan), David J. Lederer(Regeneron (United States)), Steven D. Nathan(Inova Fairfax Hospital), David Lynch, Fernando D. Martínez(University of Arizona), Thomas V. Colby(Mayo Clinic in Arizona), J. Michael Davis, Lori Lofaro(Veracyte (United States)), Murali Ramaswamy(University of Iowa), Steve D. Groshong(National Jewish Health), Hannah Neville(Veracyte (United States)), Jing Huang(Veracyte (United States)), Giulia C. Kennedy(Veracyte (United States)), Jonathan Chung(Regeneron (United States)), Karel Calero(University of South Florida), Daniel G. Pankratz(Veracyte (United States)), Yoonha Choi(Ewha Womans University), Umair Gauhar(University of Louisville), Neil M. Barth(Veracyte (United States)), Mark P. Steele(Vanderbilt University), Gerard J. Criner(Temple University Hospital)
Cited by 0
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Asthma and Wheezing in the First Six Years of Life
|New England Journal of Medicine|1995|3.8k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k